B cells may help predict risk of colitis from immunotherapy

Дата публикации: 18-09-2026 17:20:01

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Fecal microbiota transplantation may improve immunotherapy-related colitis	0	9.48	15-09-2026
2	'Invisible' inflammation in rare bowel disease may explain heightened colon cancer risk	0	6.16	22-09-2026
3	Key gut protein balances immune protection and tolerance	6	7	07-07-2026
4	Gut bacteria boost immune system, help send vitamin A to T cells	2	8	08-07-2026
5	Immune response to otherwise harmless yeast becomes a problem in Crohn’s disease	0	7	14-07-2026
6	Кишечные бактерии предскажут эффективность иммунотерапии только в сообществе	5	7	11-06-2026
7	Жирная диета неожиданно показала пользу для усиления иммунотерапии рака	6	8	10-07-2026
8	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
9	Researchers find dietary interventions may prevent inflammatory symptoms associated with Hirschsprung disease	0	7.07	23-09-2026
10	EMA recommends extension of therapeutic indications for sacituzumab govitecan	0	11.1	18-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.92. Источник: medicalxpress.com.